Stocks Abbott Laboratories

  • johnson_johnson2_logo.jpg

    Dow component and giant healthcare company--you really can't lump it in with big pharma because it sells drugs, medical devices and consumer products--Johnson & Johnson reported earnings this morning.

  • obama_barack_6.jpg

    Stocks will struggle with a heavy dose of bad earnings news that could dash investor hopes for an Obama rally in the week ahead.

  • webxtra_thumb.jpg

    In this Web Extra the traders reveal how they're gaming Bernake's Tuesday speech, a Mosaic investor meeting, the JP Morgan Healthcare conference and more.

  • graphic_word_ofthe_street.jpg

    The Dow fell for the fourth day in a row as concerns about massive losses at Citigroup knocked its shares 17 percent lower, dragging down bank stocks...

  • Stocks continued their slide Monday as the economy and what is expected to be a horrendous earnings season formed a one-two punch to knock out hopes for a January rally.

  • Stocks were stuck in negative territory Monday, with pervading worries about the recession and the ways in which quarterly earnings reports would reflect economic difficulties dominating investor concerns.

  • After starting off the year with a bang, the trend has been to the downside and is again this morning. The good news is that the credit market is continuing to improve, with lower Libor and a corporate bond market that is starting to look functional again.

  • The new year is still three weeks away, but Keith Wirtz of Fifth Third Asset Management has a couple of stocks he thinks investors ought to own in 2009.  Both are stocks of conservative companies he likes because of their fundamentals, and are likely to do well as the market recovers. 

  • Eric Schoenstein of the Jensen Portfolio says equities remain the best bet in the long run. His advice: "You've got to start thinking more clearly about fundamentals of businesses, quality businesses that have real growth potential, cash flow generation opportunities."

  • graphic_fast_money.jpg

    Investors are riddled with anxiety over one simple question. Are stocks cheap?

  • Even in a down market, there are stocks that buck the trend.

  • Cramer makes the call on viewers' favorite stocks.

  • Plus, Cramer offers young investors advice on which stocks they should consider buying and more.

  • Cramer makes the call on viewers' favorite stocks.

  • Pharmaceutical stocks were winners today on the earnings front, and CNBC guests say they can be winners on the portfolio front as well.

  • webxtra_thumb.jpg

    Despite a slowing economy, drug stocks such as Abbott Labs and Genentech posted positive earnings reports. Is health care the best defensive play in this market?

  • graphic_fast_money.jpg

    After the volatile trading of the past several days, professional and amateur investors alike are throwing in the towel. But that might be a mistake.

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • A first-of-its-kind study shows that putting hundreds of thousands of American heart patients on drugs instead of giving them a stent could save the country billions of dollars a year.

  • Boston Scientific Corp.

    Not too long ago, some had written off the potential for significant growth to resume in sales of the little wire mesh tubes that are painted with special drugs to help keep arteries from reclogging.